Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study on the Efficacy and Safety of BAT5906 Injection in the Vitreous Age-related Macular Degeneration Patients With Two Repeated Intravitreal Dose

NCT05141994 is registered in ClinicalTrials.gov with Bio-Thera Solutions as lead sponsor.

NCT NCT05141994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05141994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study on the Efficacy and Safety of BAT5906 Injection in the Vitreous Age-related Macular Degeneration Patients With Two Repeated Intravitreal Dose
Lead sponsor
Bio-Thera Solutions
Phase
Phase 2
Overall status
Completed
Start date
August 26, 2020
Completion date
September 6, 2022
Enrollment
48 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

wet age-related macular degeneration